WallStreetZenWallStreetZen

NYSE: PEN
Penumbra Inc Stock

$262.68+4.38 (+1.7%)
Updated Feb 22, 2024
Why Price Moved
PEN Price
$262.68
Fair Value Price
N/A
Market Cap
$10.14B
52 Week Low
$180.93
52 Week High
$348.67
P/E
247.81x
P/B
9.18x
P/S
9.35x
PEG
4.05x
Dividend Yield
N/A
Revenue
$995.06M
Earnings
$40.61M
Gross Margin
63.7%
Operating Margin
4.87%
Profit Margin
4.1%
Debt to Equity
0.33
Operating Cash Flow
$62M
Beta
1
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

PEN Overview

Penumbra, Inc. manufactures medical devices in the U.S. and internationally. Offerings include aspiration-based thrombectomy systems and accessory devices under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, and neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names. Penumbra was incorporated in 2004 and is headquartered in Alameda, CA.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PEN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PEN ($262.68) is trading above its intrinsic value of $28.50, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PEN is poor value based on its earnings relative to its share price (247.81x), compared to the US market average (31.94x)
P/E vs Market Valuation
PEN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more PEN due diligence checks available for Premium users.

Be the first to know about important PEN news, forecast changes, insider trades & much more!

PEN News

Valuation

PEN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
247.81x
Industry
36.93x
Market
31.94x
PEN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PEN is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

PEN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
9.18x
Industry
4.06x
PEN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

PEN price to earnings growth (PEG)

For valuing profitable companies with growth potential
PEN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

PEN's financial health

Profit margin

Revenue
$270.9M
Net Income
$9.2M
Profit Margin
3.4%
PEN's Earnings (EBIT) of $48.46M... subscribe to Premium to read more.
Interest Coverage Financials
PEN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.5B
Liabilities
$364.2M
Debt to equity
0.33
PEN's short-term assets ($868.48M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PEN's short-term assets ($868.48M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PEN's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
PEN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$30.8M
Investing
-$44.4M
Financing
$212.0k
PEN's operating cash flow ($62.41M)... subscribe to Premium to read more.
Debt Coverage Financials

PEN vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
PEN$10.14B+1.70%247.81x9.18x
SWAV$9.98B+4.61%40.20x16.60x
BIO$9.65B-0.05%-15.51x1.10x
BRKR$11.59B+2.22%38.59x9.59x
SNN$12.66B+0.98%57.72x2.42x

Penumbra Stock FAQ

What is Penumbra's quote symbol?

(NYSE: PEN) Penumbra trades on the NYSE under the ticker symbol PEN. Penumbra stock quotes can also be displayed as NYSE: PEN.

If you're new to stock investing, here's how to buy Penumbra stock.

What is the 52 week high and low for Penumbra (NYSE: PEN)?

(NYSE: PEN) Penumbra's 52-week high was $348.67, and its 52-week low was $180.93. It is currently -24.66% from its 52-week high and 45.18% from its 52-week low.

How much is Penumbra stock worth today?

(NYSE: PEN) Penumbra currently has 38,596,366 outstanding shares. With Penumbra stock trading at $262.68 per share, the total value of Penumbra stock (market capitalization) is $10.14B.

Penumbra stock was originally listed at a price of $41.30 in Sep 18, 2015. If you had invested in Penumbra stock at $41.30, your return over the last 8 years would have been 536.03%, for an annualized return of 26.02% (not including any dividends or dividend reinvestments).

How much is Penumbra's stock price per share?

(NYSE: PEN) Penumbra stock price per share is $262.68 today (as of Feb 22, 2024).

What is Penumbra's Market Cap?

(NYSE: PEN) Penumbra's market cap is $10.14B, as of Feb 23, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Penumbra's market cap is calculated by multiplying PEN's current stock price of $262.68 by PEN's total outstanding shares of 38,596,366.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.